More on NBIX
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $129.64 |
|
|||
| Open | $128.33 | ||||
| 52 Wk High | $58.46 | ||||
| 52 Wk Low | $31.25 | ||||
| Day High | $129.25 | ||||
| Day Low | $126.95 | ||||
| P/E | N/A | ||||
| EPS | $-0.69 | ||||
| Volume | 903,626 | ||||
- Form 4 NEUROCRINE BIOSCIENCES For: Mar 04 Filed by: ABERNETHY MATT
- Neurocrine Biosciences to Present at Upcoming Investor Conferences in March
- RBC Capital: 'We see upside in multiple scenarios, and so would remain buyers'
- Form 4 NEUROCRINE BIOSCIENCES For: Feb 20 Filed by: Onyia Jude
- Wolfe Research Starts Neurocrine Bio. (NBIX) at Outperform
- Form 4 NEUROCRINE BIOSCIENCES For: Feb 12 Filed by: ABERNETHY MATT
- Form 4 NEUROCRINE BIOSCIENCES For: Feb 12 Filed by: Boyer David W.
- Form 4 NEUROCRINE BIOSCIENCES For: Feb 12 Filed by: Gano Kyle
- Form 4 NEUROCRINE BIOSCIENCES For: Feb 12 Filed by: Onyia Jude
- Form 4 NEUROCRINE BIOSCIENCES For: Feb 12 Filed by: BENEVICH ERIC
Entities mentioned with NBIX
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- PDUFA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
